Simulations Plus Stock
Simulations Plus Stock
We can see a decrease in the price for Simulations Plus. Compared to yesterday it has lost -€0.400 (-2.440%).
With 11 Buy predictions and not the single Sell prediction the community is currently very high on Simulations Plus.
As a result the target price of 31 € shows a very positive potential of 89.02% compared to the current price of 16.4 € for Simulations Plus.
Pros and Cons of Simulations Plus in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
G***** c******* t* c**********
Cons
?
S********** s********
?
M***** P*******
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Simulations Plus vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Simulations Plus | -2.440% | - | - | - | - | - | - |
| MicroVision Inc | -3.090% | 1.464% | -4.680% | -26.260% | -48.555% | -63.238% | -85.474% |
| Fonar Corp. New | 0.800% | 0.800% | 4.132% | -11.888% | -11.268% | -19.231% | -11.268% |
| Fluidigm Corp. | 2.190% | 7.692% | 19.658% | -20.000% | -18.129% | 25.786% | -74.865% |
Comments
Simulations Plus (NASDAQ:SLP) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Show more
Ratings data for SLP provided by MarketBeat
Simulations Plus, Inc. (NASDAQ: SLP) had its "outperform" rating re-affirmed by analysts at William Blair.
Show more
Ratings data for SLP provided by MarketBeat
Simulations Plus, Inc. (NASDAQ: SLP) had its price target lowered by analysts at Stephens from $28.00 to $20.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for SLP provided by MarketBeat
News
Simulations Plus Invests in Clinical Development Technology Company Nurocor
Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical
